Vitamin B3 is the nutritional category including nicotinic acid and nicotinamide, compounds the body can use to make nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate. These coenzymes participate in metabolism, including transfer of reducing equivalents between reactions. Adequate dietary supply supports a reusable biochemical system rather than providing the bulk of the body's fuel.[ref]
For example, an oxidized coenzyme can accept reducing equivalents in one reaction and transfer them in another. The coenzyme is regenerated during the cycle, so its importance is not measured by how much of it is burned for energy. Humans can also derive niacin equivalents from tryptophan; severe inadequacy is associated with pellagra.[ref]
Pellagra is a disease caused by severe vitamin B3 deficiency. Its manifestations can include sun-sensitive dermatitis, diarrhea and neurological changes, including dementia. These familiar “three Ds” summarize possible effects; they are not a requirement that every affected person show all three. Vitamin B3 supplies precursors of nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate, so adequate dietary energy alone does not guarantee adequate support for metabolism.[ref]
In 1915, Joseph Goldberger and G. A. Wheeler tested a restricted, cereal-heavy diet at a Mississippi prison farm. At least six of eleven remaining volunteers developed signs judged to be pellagra within five months; none were observed among the comparison prisoners. The reported menu supplied about 2,952 calories per man per day, making the contrast between calories and dietary composition especially revealing. Prisoners were offered pardons for participation; allocation was not described as randomized.[ref]
The experiment supported a dietary cause under its conditions. It did not identify the missing molecule chemically: demonstrating that a restricted diet produces a disease and identifying the specific vitamin are different experimental achievements.

Articles by others on the same topic (0)

There are currently no matching articles.